Premium Information is available for this item - Upgrade for $1 a day
6505-01-004-3546
Usp Trifluoperazine Hydrochloride Tablets
6505010043546 010043546 484-0S07-21 STELAZINE
June 2023
7
Marketplace 6505-01-004-3546
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-004-3546 5+ Documents (More...)
Usp Trifluoperazine Hydrochloride Tablets 6505-01-004-3546 6505010043546 010043546 TRIFLUOPERAZINE
Usp Trifluoperazine Hydrochloride Tablets 6505-01-004-3546 6505010043546 010043546 TRIFLUOPERAZINE
your web browser . 6505-66-020 -2250Trifluoperazine Tab6505660202250 660202250STELAZINE TABLETS STELAZINE
NDC00108-4903-20 NDC00378 -2401-01 Managed by United States NSN Created on 1 Jan 1960 STELAZINE TABLETS
Usp Trifluoperazine Hydrochloride Tablets STELAZINE CONCENTRATESTELAZINENDC00108-4901-42NDC00781
States NSN Created on 15 May 1968 Data TABLETS STELAZINE NDC00108-4903-20 NDC00378-2401-01 Managed by
TABLETS STELAZINE NDC00781-1036-10 Managed by United States NSN Created on 15 May 1968 Data Last Changed
CONCENTRATE STELAZINE NDC00108-4901-42 NDC00781-4045-02 NDC00484-4901-42 Managed by United States NSN
Restrictions 6505-01-004-3546
6505-01-004-3546 is a Usp Trifluoperazine Hydrochloride Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-004-3546
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-004-3546
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-004-3546
- Part Number
- Manufacturer
- Status
- 484-0S07-21
- Manufacturer
- 93544 - Glaxosmithkline Holdings (Americas) (Obsolete)
- Original Design
- Original Design
- STELAZINE
- 93544 - Glaxosmithkline Holdings (Americas) (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-01-004-3546
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 10.000 Milligrams Trifluoperazine Hydrochloride Active Ingredient
- Primary Container Type [CQCT]
- Strip
- Primary Container Content Quantity [CRLK]
- 10.000 Tablets
- Total Primary Container Quantity [CSCW]
- 10
- Special Features [FEAT]
- Administration:Oral Nonchewable;
NATO Stock Numbers Related to 6505-01-004-3546
Freight Information 6505-01-004-3546
6505-01-004-3546 has freight characteristics.. 6505-01-004-3546 has a variance between NMFC and UFC when transported by rail and the description should be consulted.